How can clinical safety and efficacy concerns in stem cell therapy for spinal cord injury be overcome?

References

• Lee BB, Cripps RA, Fitzharris M, et al. The global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate. Spinal Cord. 2014;52(2):110–116. doi: 10.1038/sc.2012.158
   PubMed Web of Science ®Google Scholar
• National Spinal Cord Injury Statistical Center (NSCIS), University of Alabama at Birmingham. Spinal cord injury facts and figures at a glance (2022). [Internet]. Available from: https://www.nscisc.uab.edu/public/Facts%20and%20Figures%202022%20-%20English%20Final.pdf.
   Google Scholar
• Chiu W-T, Lin H-C, Lam C, et al. Review paper: epidemiology of traumatic spinal cord injury: comparisons between developed and developing countries. Asia Pac J Public Health. 2010;22(1):9–18. doi: 10.1177/1010539509355470
   PubMed Web of Science ®Google Scholar
• Hejrati N, Moghaddamjou A, Pedro K, et al. Current practice of acute spinal cord injury management: a global survey of members from the AO spine. Global Spine J. 2022;21925682221116890:219256822211168. doi: 10.1177/21925682221116888
   Google Scholar
• Hejrati N, Rocos B, Fehlings MG. Controversies in cervical spine trauma: the role of timing of surgical decompression and the use of methylprednisolone sodium succinate in spinal cord injury. A narrative and updated systematic review. Indian Spine J. 2022;5(1):47. doi: 10.4103/ISJ.ISJ_26_21
   Google Scholar
• Badhiwala JH, Wilson JR, Witiw CD, et al. The influence of timing of surgical decompression for acute spinal cord injury: a pooled analysis of individual patient data. Lancet Neurol. 2021;20(2):117–126. doi: 10.1016/S1474-4422(20)30406-3
   PubMed Web of Science ®Google Scholar
• Hejrati N, Fehlings MG. A review of emerging neuroprotective and neuroregenerative therapies in traumatic spinal cord injury. Curr Opin Pharmacol. 2021;60:331–340. doi: 10.1016/j.coph.2021.08.009
   PubMed Web of Science ®Google Scholar
• Hejrati N, McIntyre WB, Pieczonka K, et al.et al. Chapter 31 - translational research in spinal cord injury – what is in the future? In: Fehlings M, Kwon B Vaccaro A, editors. Neural repair and regeneration after spinal cord injury and spine trauma [internet]. Academic Press; 2022 [cited 2022 Jul 25]. p. 587–602. Available from; https://www.sciencedirect.com/science/article/pii/B9780128198353000137.
   Google Scholar
• Ahuja CS, Mothe A, Khazaei M, et al. The leading edge: Emerging neuroprotective and neuroregenerative cell-based therapies for spinal cord injury. Stem Cells Transl Med. 2020;9(12):1509–1530. doi: 10.1002/sctm.19-0135
   PubMed Web of Science ®Google Scholar
• Assinck P, Duncan GJ, Hilton BJ, et al. Cell transplantation therapy for spinal cord injury. Nat Neurosci. 2017;20(5):637–647. doi: 10.1038/nn.4541
   PubMed Web of Science ®Google Scholar
• Zipser CM, Cragg JJ, Guest JD, et al. Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trials. Lancet Neurol. 2022;21(7):659–670. doi: 10.1016/S1474-4422(21)00464-6
   PubMed Web of Science ®Google Scholar
• Moore TJ, Heyward J, Anderson G, et al. Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study. BMJ Open. 2020;10(6):e038863. doi: 10.1136/bmjopen-2020-038863
   PubMed Web of Science ®Google Scholar
• Broder MS, Quock TP, Chang E, et al. The cost of hematopoietic stem-cell transplantation in the United States. Am Health Drug Benefits. 2017;10:366–374.
   PubMed Web of Science ®Google Scholar
• Betz R, Biering-Sørensen F, Burns SP, et al. The 2019 revision of the international standards for neurological classification of spinal cord injury (ISNCSCI)—what’s new? Spinal Cord. 2019;57:815–817.
   PubMed Web of Science ®Google Scholar
• Kirshblum S, Snider B, Eren F, et al. Characterizing natural recovery after traumatic spinal cord injury. J Neurotrauma. 2021;38(9):1267–1284. doi: 10.1089/neu.2020.7473
   PubMed Web of Science ®Google Scholar
• Badhiwala JH, Wilson JR, Kulkarni AV, et al. A novel method to classify cervical incomplete spinal cord injury based on potential for recovery: a group-based trajectory analysis. J Neurotrauma. 2022;39(23–24):1654–1664. doi: 10.1089/neu.2022.0145
   PubMed Web of Science ®Google Scholar
• Fehlings MG, Pedro K, Hejrati N. The management of acute spinal cord injury: where have we been? Where are we now? Where are we going? J Neurotrauma. [cited 2022 Jul 25] 2022;39(23–24):1591–1602. InternetAvailable from: https://www.liebertpub.com/doi/abs/10.1089/neu.2022.0009.
   PubMed Web of Science ®Google Scholar
• van der Weijden CWJ, García DV, Borra RJH, et al. Myelin quantification with MRI: A systematic review of accuracy and reproducibility. Neuroimage. 2021;226:117561. doi: 10.1016/j.neuroimage.2020.117561
   PubMed Web of Science ®Google Scholar
• Dell’anno MT, Wang X, Onorati M, et al. Human neuroepithelial stem cell regional specificity enables spinal cord repair through a relay circuit. Nat Commun. 2018;9(1):3419. doi: 10.1038/s41467-018-05844-8
   PubMedGoogle Scholar
• Kadoya K, Lu P, Nguyen K, et al. Spinal cord reconstitution with homologous neural grafts enables robust corticospinal regeneration. Nat Med. 2016;22(5):479–487. doi: 10.1038/nm.4066
   PubMed Web of Science ®Google Scholar
• Kajikawa K, Imaizumi K, Shinozaki M, et al. Cell therapy for spinal cord injury by using human Ipsc-derived region-specific neural progenitor cells. Mol Brain. 2020;13(1):120. doi: 10.1186/s13041-020-00662-w
   PubMed Web of Science ®Google Scholar
• Tao Y, Zhang S-C. Neural subtype specification from human pluripotent stem cells. Cell Stem Cell. 2016;19(5):573–586. doi: 10.1016/j.stem.2016.10.015
   PubMed Web of Science ®Google Scholar
• Wu P, Tarasenko YI, Gu Y, et al. Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nat Neurosci. 2002;5(12):1271–1278. doi: 10.1038/nn974
   PubMed Web of Science ®Google Scholar
• Zholudeva LV, Iyer N, Qiang L, et al. Transplantation of neural progenitors and v2a interneurons after spinal cord injury. J Neurotrauma. 2018;35(24):2883–2903. doi: 10.1089/neu.2017.5439
   PubMed Web of Science ®Google Scholar
• Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma. 2011;28(8):1611–1682. doi: 10.1089/neu.2009.1177
   PubMed Web of Science ®Google Scholar
• Dasari VR, Veeravalli KK, Dinh DH. Mesenchymal stem cells in the treatment of spinal cord injuries: A review. World J Stem Cells. 2014;6(2):120–133. doi: 10.4252/wjsc.v6.i2.120
   PubMedGoogle Scholar
• Richardson PM, McGuinness UM, Aguayo AJ. Axons from CNS neurons regenerate into PNS grafts. Nature. 1980;284(5753):264–265. doi: 10.1038/284264a0
   PubMed Web of Science ®Google Scholar
• Boyd JG, Skihar V, Kawaja M, et al. Olfactory ensheathing cells: Historical perspective and therapeutic potential. The anatomical record part B. Anat Rec. 2003;271B(1):49–60. doi: 10.1002/ar.b.10011
   Google Scholar
• Mackay-Sim A, Féron F, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain. 2008;131(9):2376–2386. doi: 10.1093/brain/awn173
   PubMed Web of Science ®Google Scholar
• Mothe AJ, Zahir T, Santaguida C, et al. Neural stem/progenitor cells from the adult human spinal cord are multipotent and self-renewing and differentiate after transplantation. PLoS One. 2011;6(11):e27079. doi: 10.1371/journal.pone.0027079
   PubMed Web of Science ®Google Scholar
• Rustenhoven J, Park T-H, Schweder P, et al. Isolation of highly enriched primary human microglia for functional studies. Sci Rep. 2016;6(1):19371. doi: 10.1038/srep19371
   PubMedGoogle Scholar
• Chaddah R, Arntfield M, Runciman S, et al. Clonal Neural Stem Cells from Human Embryonic Stem Cell Colonies. J Neurosci. 2012;32(23):7771–7781. doi: 10.1523/JNEUROSCI.3286-11.2012
   PubMed Web of Science ®Google Scholar
• Umebayashi D, Coles B, van der Kooy D. Enrichment of oligodendrocyte progenitors from differentiated neural precursors by clonal sphere preparations. Stem Cells Dev. 2016;25(9):712–728. doi: 10.1089/scd.2015.0244
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–676. doi: 10.1016/j.cell.2006.07.024
   PubMed Web of Science ®Google Scholar
• Khazaei M, Ahuja CS, Fehlings MG. Induced pluripotent stem cells for traumatic spinal cord injury. Front Cell Dev Biol. 2017 [[cited 2023 Mar 12]];4. InternetAvailable from: https://www.frontiersin.org/articles/10.3389/fcell.2016.00152.
   PubMed Web of Science ®Google Scholar
• Khazaei M, Ahuja CS, Fehlings MG. Generation of oligodendrogenic spinal neural progenitor cells from human induced pluripotent stem cells. Curr Protoc Stem Cell Biol. 2017;42(1):D.2.20.1–D.2.20.14. doi: 10.1002/cpsc.31
   Google Scholar
• Khazaei M, Ahuja CS, Rodgers CE, et al. Generation of definitive neural progenitor cells from human pluripotent stem cells for transplantation into spinal cord injury. Methods Mol Biol. 2019;1919:25–41.
   PubMedGoogle Scholar
• Nagoshi N, Okano H, Nakamura M. Regenerative therapy for spinal cord injury using iPSC technology. Inflamm Regen. 2020;40(1):40. doi: 10.1186/s41232-020-00149-0
   PubMed Web of Science ®Google Scholar
• Silvestro S, Bramanti P, Trubiani O, et al. Stem cells therapy for spinal cord injury: an overview of clinical trials. Int J Mol Sci. 2020;21(2):659. doi: 10.3390/ijms21020659
   PubMed Web of Science ®Google Scholar
• Ribeiro BF, da Cruz BC, de Sousa BM, et al. Cell therapies for spinal cord injury: a review of the clinical trials and cell-type therapeutic potential. Brain. 2023;146(7):2672–2693. doi: 10.1093/brain/awad047
   PubMed Web of Science ®Google Scholar
• Yamazaki K, Kawabori M, Seki T, et al. Clinical trials of stem cell treatment for spinal cord injury. Int J Mol Sci. 2020;21(11):3994. doi: 10.3390/ijms21113994
   PubMed Web of Science ®Google Scholar
• Goodman BS, Posecion LWF, Mallempati S, et al. Complications and pitfalls of lumbar interlaminar and transforaminal epidural injections. Curr Rev Musculoskelet Med. 2008;1(3–4):212–222. doi: 10.1007/s12178-008-9035-2
   PubMedGoogle Scholar
• Manabe N, Shimizu T, Tanouchi T, et al. A novel skull clamp positioning system and technique for posterior cervical surgery. Medicine (Baltimore). 2015;94(17):e695. doi: 10.1097/MD.0000000000000695
   PubMed Web of Science ®Google Scholar
• Khoramnia R, Yildirim TM, Weindler J, et al. Preloaded injectors used in a clinical study: videographic assessment and laboratory analysis of injector nozzle damage. J Cataract Refract Surg. 2021;47(10):1338. doi: 10.1097/j.jcrs.0000000000000587
   PubMed Web of Science ®Google Scholar
• D’Souza M, Gendreau J, Feng A, et al. Robotic-assisted spine surgery: history, efficacy, cost, and future trends. Robot Surg. 2019;6:9–23. doi: 10.2147/RSRR.S190720
   PubMedGoogle Scholar
• Chio JCT, Punjani N, Hejrati N, et al. Extracellular matrix and oxidative stress following traumatic spinal cord injury: physiological and pathophysiological roles and opportunities for therapeutic intervention. Antioxid Redox Signaling. 2022;37(1–3):184–207. doi: 10.1089/ars.2021.0120
   PubMed Web of Science ®Google Scholar
• Hou Y, Liu X, Guo Y, et al. Strategies for effective neural circuit reconstruction after spinal cord injury: use of stem cells and biomaterials. World Neurosurg. 2022;161:82–89. doi: 10.1016/j.wneu.2022.02.012
   PubMed Web of Science ®Google Scholar
• Papa S, Pizzetti F, Perale G, et al. Regenerative medicine for spinal cord injury: focus on stem cells and biomaterials. Expert Opin Biol Ther. 2020;20(10):1203–1213. doi: 10.1080/14712598.2020.1770725
   PubMed Web of Science ®Google Scholar
• Kolosnjaj-Tabi J, Wilhelm C, Clément O, et al. Cell labeling with magnetic nanoparticles: opportunity for magnetic cell imaging and cell manipulation. J Nanobiotechnol. 2013;11(S1):S7. doi: 10.1186/1477-3155-11-S1-S7
   PubMedGoogle Scholar
• Labusca L, Herea DD, Mashayekhi K. Stem cells as delivery vehicles for regenerative medicine-challenges and perspectives. World J Stem Cells. 2018;10(5):43–56. doi: 10.4252/wjsc.v10.i5.43
   PubMed Web of Science ®Google Scholar
• Khaddour K, Hana CK, Mewawalla P Hematopoietic Stem Cell Transplantation. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Apr 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK536951/.
   Google Scholar
• Lavorato A, Raimondo S, Boido M, et al. Mesenchymal stem cell treatment perspectives in peripheral nerve regeneration: systematic review. Int J Mol Sci. 2021;22(2):572. doi: 10.3390/ijms22020572
   PubMed Web of Science ®Google Scholar
• Paul C, Samdani AF, Betz RR, et al. Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methodsVol. 34. Philadephia, United States: Spine (Phila Pa 1976); 2009p. 328–334.
   Google Scholar
• Musiał-Wysocka A, Kot M, Majka M. The pros and cons of mesenchymal stem cell-based therapies. Cell Transplant. 2019;28(7):801–812. doi: 10.1177/0963689719837897
   PubMed Web of Science ®Google Scholar
• Baldari S, Di Rocco G, Piccoli M, et al. Challenges and strategies for improving the regenerative effects of mesenchymal stromal cell-based therapies. Int J Mol Sci. 2017;18(10):2087. doi: 10.3390/ijms18102087
   PubMed Web of Science ®Google Scholar
• Lavoie NS, Truong V, Malone D, et al. Human induced pluripotent stem cells integrate, create synapses and extend long axons after spinal cord injury. J Cell Mol Med. 2022;26(7):1932–1942. doi: 10.1111/jcmm.17217
   PubMed Web of Science ®Google Scholar
• Li J, Lepski G. Cell transplantation for spinal cord injury: a systematic review. Biomed Res Int. 2013;2013:786475. doi: 10.1155/2013/786475
   PubMed Web of Science ®Google Scholar
• Muheremu A, Shu L, Liang J, et al. Sustained delivery of neurotrophic factors to treat spinal cord injury. Transl Neurosci. 2021;12(1):494–511. doi: 10.1515/tnsci-2020-0200
   PubMed Web of Science ®Google Scholar
• Ericson T, Singla P, Kohan L. Intrathecal pumps. Phys Med Rehabil Clin N Am. 2022;33(2):409–424. doi: 10.1016/j.pmr.2022.01.004
   PubMed Web of Science ®Google Scholar
• Salehi MS, Safari A, Pandamooz S, et al. The beneficial potential of genetically modified stem cells in the treatment of stroke: a review. Stem Cell Rev And Rep. 2022;18(2):412–440. doi: 10.1007/s12015-021-10175-1
   PubMed Web of Science ®Google Scholar
• Khazaei M, Ahuja CS, Nakashima H, et al. GDNF rescues the fate of neural progenitor grafts by attenuating Notch signals in the injured spinal cord in rodents. Sci Transl Med. 2020;12(525):eaau3538. doi: 10.1126/scitranslmed.aau3538
   PubMed Web of Science ®Google Scholar
• JI W, ZHANG X, JI L, et al. Effects of brain-derived neurotrophic factor and neurotrophin-3 on the neuronal differentiation of rat adipose-derived stem cells. Mol Med Rep. 2015;12(4):4981–4988. doi: 10.3892/mmr.2015.4099
   PubMed Web of Science ®Google Scholar
• Howard D, Buttery LD, Shakesheff KM, et al. Tissue engineering: strategies, stem cells and scaffolds. J Anat. 2008;213(1):66–72. doi: 10.1111/j.1469-7580.2008.00878.x
   PubMed Web of Science ®Google Scholar
• Yang T, Dai Y, Chen G, et al. Dissecting the dual role of the glial scar and scar-forming astrocytes in spinal cord injury. Front Cell Neurosci. 2020;14:78. doi: 10.3389/fncel.2020.00078
   PubMed Web of Science ®Google Scholar
• Qian K, Xu T-Y, Wang X, et al. Effects of neural stem cell transplantation on the motor function of rats with contusion spinal cord injuries: a meta-analysis. Neural Regen Res. 2019;15(4):748–758. doi: 10.4103/1673-5374.266915
   Web of Science ®Google Scholar
• Facts and figures 2020.Pdf [Internet]. [cited 2022 Dec 19]. Available from: https://www.nscisc.uab.edu/Public/Facts%20and%20Figures%202020.pdf.
   Google Scholar
• Bradbury EJ, Moon LDF, Popat RJ, et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 2002;416(6881):636–640. doi: 10.1038/416636a
   PubMed Web of Science ®Google Scholar
• Takiguchi M, Miyashita K, Yamazaki K, et al. Chondroitinase ABC administration facilitates serotonergic innervation of motoneurons in rats with complete spinal cord transection. Front Integr Neurosci. 2022;16:881632. doi: 10.3389/fnint.2022.881632
   PubMed Web of Science ®Google Scholar
• Ohtake Y, Saito A, Li S. Diverse functions of protein tyrosine phosphatase σ in the nervous and immune systems. Exp Neurol. 2018;302:196–204. doi: 10.1016/j.expneurol.2018.01.014
   PubMed Web of Science ®Google Scholar
• Lang B, Cregg J, DePaul M, et al. Modulation of the proteoglycan receptor PTPσ promotes recovery after spinal cord injury. Nature. 2015;518(7539):404–408. doi: 10.1038/nature13974
   PubMed Web of Science ®Google Scholar
• Damasceno PKF, de Santana TA, Santos GC, et al. Genetic engineering as a strategy to improve the therapeutic efficacy of mesenchymal stem/stromal cells in regenerative medicine. Front Cell Dev Biol. 2020; [[cited 2023 Apr 24]]. 8. InternetAvailable from: https://www.frontiersin.org/articles/10.3389/fcell.2020.00737
   PubMed Web of Science ®Google Scholar
• Suzuki H, Imajo Y, Funaba M, et al. Current concepts of biomaterial scaffolds and regenerative therapy for spinal cord injury. Int J Mol Sci. 2023;24(3):2528. doi: 10.3390/ijms24032528
   PubMed Web of Science ®Google Scholar
• Brown N. INSPIRE neuro-spinal ScaffoldTM: an implantable alternative to stem-cell therapy for endogenous repair in spinal cord injury. J Korean Neurosurg Soc. 2020;63:671–672. doi: 10.3340/jkns.2020.0003
   PubMed Web of Science ®Google Scholar
• Kim KD, Lee KS, Coric D, et al. Acute Implantation of a bioresorbable polymer scaffold in patients with complete thoracic spinal cord injury: 24-month follow-up from the INSPIRE study. Neurosurgery. 2022;90(6):668–675. doi: 10.1227/neu.0000000000001932
   PubMed Web of Science ®Google Scholar
• Karimi-Abdolrezaee S, Eftekharpour E, Wang J, et al. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci. 2006;26(13):3377–3389. doi: 10.1523/JNEUROSCI.4184-05.2006
   PubMed Web of Science ®Google Scholar
• Mothe AJ, Tam RY, Zahir T, et al. Repair of the injured spinal cord by transplantation of neural stem cells in a hyaluronan-based hydrogel. Biomaterials. 2013;34(15):3775–3783. doi: 10.1016/j.biomaterials.2013.02.002
   PubMed Web of Science ®Google Scholar
• Johnson PJ, Parker SR, Sakiyama-Elbert SE. Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury. J Biomed Mater Res A. 2010;92(1):152–163. doi: 10.1002/jbm.a.32343
   PubMedGoogle Scholar
• Liu Y, Ye H, Satkunendrarajah K, et al. A self-assembling peptide reduces glial scarring, attenuates post-traumatic inflammation and promotes neurological recovery following spinal cord injury. Acta Biomater. 2013;9(9):8075–8088. doi: 10.1016/j.actbio.2013.06.001
   PubMed Web of Science ®Google Scholar
• Barrow M, Taylor A, Murray P, et al. Design considerations for the synthesis of polymer coated iron oxide nanoparticles for stem cell labelling and tracking using MRI. Chem Soc Rev. 2015;44(19):6733–6748. doi: 10.1039/C5CS00331H
   PubMed Web of Science ®Google Scholar
• Ngen EJ, Wang L, Kato Y, et al. Imaging transplanted stem cells in real time using an MRI dual-contrast method. Sci Rep. 2015;5(1):13628. doi: 10.1038/srep13628
   PubMedGoogle Scholar
• Kraitchman DL, Bulte JWM. Imaging of stem cells using MRI. Basic Res Cardiol. 2008;103(2):105–113. doi: 10.1007/s00395-008-0704-5
   PubMed Web of Science ®Google Scholar
• Küstermann E, Himmelreich U, Kandal K, et al. Efficient stem cell labeling for MRI studies. Contrast Media Mol Imaging. 2008;3(1):27–37. doi: 10.1002/cmmi.229
   PubMed Web of Science ®Google Scholar
• Alizadeh A, Dyck SM, Karimi-Abdolrezaee S. Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms. Front Neurol. 2019 [[cited 2023 Jul 12]];10. InternetAvailable from https://www.frontiersin.org/articles/10.3389/fneur.2019.00282
   PubMed Web of Science ®Google Scholar
• Pahwa R, Goyal A, Jialal I Chronic inflammation. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Jul 14]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK493173/.
   Google Scholar
• Adegeest CY, van Gent JAN, Stolwijk-Swüste JM, et al. Influence of severity and level of injury on the occurrence of complications during the subacute and chronic stage of traumatic spinal cord injury: a systematic review. J Neurosurg Spine. 2022;36(4):632–652. doi: 10.3171/2021.7.SPINE21537
   PubMed Web of Science ®Google Scholar
• Tashiro S, Nakamura M, Okano H. Regenerative rehabilitation and stem cell therapy targeting chronic spinal cord injury: a review of preclinical studies. Cells. 2022;11(4):685. doi: 10.3390/cells11040685
   PubMed Web of Science ®Google Scholar
• Fan X-L, Zhang Y, Li X, et al. Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell Mol Life Sci. 2020;77(14):2771–2794. doi: 10.1007/s00018-020-03454-6
   PubMed Web of Science ®Google Scholar
• Sezer N, Akkuş S, Uğurlu FG. Chronic complications of spinal cord injury. World J Orthop. 2015;6(1):24–33. doi: 10.5312/wjo.v6.i1.24
   PubMed Web of Science ®Google Scholar
• Clifford T, Finkel Z, Rodriguez B, et al. Current advancements in spinal cord injury research—glial scar formation and neural regeneration. Cells. 2023;12(6):853. doi: 10.3390/cells12060853
   PubMed Web of Science ®Google Scholar
• Li Z, Yu S, Hu X, et al. Fibrotic scar after spinal cord injury: crosstalk with other cells, cellular origin, function, and mechanism. Front Cell Neurosci. 2021; [[cited 2023 Jul 12]]. 15. Available from: https://www.frontiersin.org/articles/10.3389/fncel.2021.720938
   Web of Science ®Google Scholar
• Moreau A, Varey E, Anegon I, et al. Effector mechanisms of rejection. Cold Spring Harb Perspect Med. 2013;3(11):a015461. doi: 10.1101/cshperspect.a015461
   PubMed Web of Science ®Google Scholar
• Wang P, Jiang Z, Wang C, et al. Immune tolerance induction using cell-based strategies in liver transplantation: clinical perspectives. Front Immunol. 2020 [[cited 2023 Apr 24]];11. InternetAvailable from: https://www.frontiersin.org/articles/10.3389/fimmu.2020.01723
   Web of Science ®Google Scholar
• Kim S, Hupperetz C, Lim S, et al. Genome editing of immune cells using CRISPR/Cas9. BMB Rep. 2021;54(1):59–69. doi: 10.5483/BMBRep.2021.54.1.245
   PubMed Web of Science ®Google Scholar
• Deuse T, Hu X, Gravina A, et al. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients. Nat Biotechnol. 2019;37(3):252–258. doi: 10.1038/s41587-019-0016-3
   PubMed Web of Science ®Google Scholar
• Trounson A, Boyd NR, Boyd RL. Toward a universal solution: editing compatibility into pluripotent stem cells. Cell Stem Cell. 2019;24(4):508–510. doi: 10.1016/j.stem.2019.03.003
   PubMed Web of Science ®Google Scholar
• Lanza R, Russell DW, Nagy A. Engineering universal cells that evade immune detection. Nat Rev Immunol. 2019;19(12):723–733. doi: 10.1038/s41577-019-0200-1
   PubMed Web of Science ®Google Scholar
• Hussain Y, Khan H. Immunosuppressive drugs. Encyclopedia Infect Immun. 2022;726–740 doi: 10.1016/B978-0-12-818731-9.00068-9
   Google Scholar
• Vazirabad I, Chhabra S, Nytes J, et al. Direct HLA genetic comparisons identify highly matched unrelated donor-recipient pairs with improved transplantation outcome. Biol Blood Marrow Transplant. 2019;25(5):921–931. doi: 10.1016/j.bbmt.2018.12.006
   PubMed Web of Science ®Google Scholar
• Wang Z, Zheng J, Pan R, et al. Current status and future prospects of patient-derived induced pluripotent stem cells. Hum Cell. 2021;34(6):1601–1616. doi: 10.1007/s13577-021-00592-2
   PubMed Web of Science ®Google Scholar
• Bell S, Hettige NC, Silveira H, et al. Differentiation of Human Induced Pluripotent Stem Cells (iPscs) into an effective model of forebrain neural progenitor cells and mature neurons. Bio Protoc. 2019;9(5):e3188. doi: 10.21769/BioProtoc.3188
   PubMed Web of Science ®Google Scholar
• Al Abbar A, Ngai SC, Nograles N, et al. Induced pluripotent stem cells: reprogramming platforms and applications in cell replacement therapy. Biores Open Access. 2020;9(1):121–136. doi: 10.1089/biores.2019.0046
   PubMed Web of Science ®Google Scholar
• Wertheim L, Edri R, Goldshmit Y, et al. Regenerating the injured spinal cord at the chronic phase by engineered iPscs-derived 3D neuronal networks. Adv Sci. 2022;9(11):e2105694. doi: 10.1002/advs.202105694
   Web of Science ®Google Scholar
• Werbowetski-Ogilvie TE, Bossé M, Stewart M, et al. Characterization of human embryonic stem cells with features of neoplastic progression. Nat Biotechnol. 2009;27(1):91–97. doi: 10.1038/nbt.1516
   PubMed Web of Science ®Google Scholar
• Merkle FT, Ghosh S, Kamitaki N, et al. Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature. 2017;545(7653):229–233. doi: 10.1038/nature22312
   PubMed Web of Science ®Google Scholar
• Amps K, Andrews PW, Anyfantis G, et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol. 2011;29:1132–1144.
   PubMed Web of Science ®Google Scholar
• Werbowetski‐Ogilvie TE, Morrison LC, Fiebig‐Comyn A, et al. In Vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation. Stem Cells. 2012;30(3):392–404. doi: 10.1002/stem.1017
   PubMed Web of Science ®Google Scholar
• Lund RJ, Närvä E, Lahesmaa R. Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet. 2012;13(10):732–744. doi: 10.1038/nrg3271
   PubMed Web of Science ®Google Scholar
• Ross AL, Leder DE, Weiss J, et al. Genomic instability in cultured stem cells: associated risks and underlying mechanisms. Regen Med. 2011;6(5):653–662. doi: 10.2217/rme.11.44
   PubMed Web of Science ®Google Scholar
• Poetsch MS, Strano A, Guan K. Human induced pluripotent stem cells: from cell origin, genomic stability, and epigenetic memory to translational medicine. Stem Cells. 2022;40(6):546–555. doi: 10.1093/stmcls/sxac020
   PubMed Web of Science ®Google Scholar
• Garitaonandia I, Amir H, Boscolo FS, et al. Increased risk of genetic and epigenetic instability in human embryonic stem cells associated with specific culture conditions. PLoS One. 2015;10(2):e0118307. doi: 10.1371/journal.pone.0118307
   PubMed Web of Science ®Google Scholar
• Stephenson E, Ogilvie CM, Patel H, et al. Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells. J R Soc Interface. 2010;7(suppl_6):S677–S688. doi: 10.1098/rsif.2010.0343.focus
   PubMedGoogle Scholar
• Nguyen HT, Geens M, Mertzanidou A, et al. Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-Xl. Mol Hum Reprod. 2014;20(2):168–177. doi: 10.1093/molehr/gat077
   PubMed Web of Science ®Google Scholar
• Avery S, Hirst AJ, Baker D, et al. BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures. Stem Cell Rep. 2013;1(5):379–386. doi: 10.1016/j.stemcr.2013.10.005
   PubMed Web of Science ®Google Scholar
• Iwatani M, Ikegami K, Kremenska Y, et al. Dimethyl sulfoxide has an impact on epigenetic profile in mouse embryoid body. Stem Cells. 2006;24(11):2549–2556. doi: 10.1634/stemcells.2005-0427
   PubMed Web of Science ®Google Scholar
• Diaferia GR, Dessì SS, Deblasio P, et al. Is stem cell chromosomes stability affected by cryopreservation conditions? Cytotechnology. 2008;58(1):11–16. doi: 10.1007/s10616-008-9163-y
   PubMed Web of Science ®Google Scholar
• Mayshar Y, Ben-David U, Lavon N, et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell. 2010;7(4):521–531. doi: 10.1016/j.stem.2010.07.017
   PubMed Web of Science ®Google Scholar
• Närvä E, Autio R, Rahkonen N, et al. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol. 2010;28(4):371–377. doi: 10.1038/nbt.1615
   PubMed Web of Science ®Google Scholar
• Hussein SM, Batada NN, Vuoristo S, et al. Copy number variation and selection during reprogramming to pluripotency. Nature. 2011;471(7336):58–62. doi: 10.1038/nature09871
   PubMed Web of Science ®Google Scholar
• Laurent LC, Ulitsky I, Slavin I, et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPscs during reprogramming and time in culture. Cell Stem Cell. 2011;8(1):106–118. doi: 10.1016/j.stem.2010.12.003
   PubMed Web of Science ®Google Scholar
• Grespi V, Caprera C, Ricciolini C, et al. Human neural stem cells drug product: microsatellite instability analysis. PLoS One. 2022;17(8):e0273679. doi: 10.1371/journal.pone.0273679
   PubMed Web of Science ®Google Scholar
• Wu H, Kim KJ, Mehta K, et al. Copy number variant analysis of human embryonic stem cells. Stem Cells. 2008;26(6):1484–1489. doi: 10.1634/stemcells.2007-0993
   PubMed Web of Science ®Google Scholar
• Liang Q, Conte N, Skarnes WC, et al. Extensive genomic copy number variation in embryonic stem cells. Proc Natl Acad Sci, USA. 2008;105(45):17453–17456. doi: 10.1073/pnas.0805638105
   PubMed Web of Science ®Google Scholar
• Li YR, van Setten J, Verma SS, et al. Concept and design of a genome-wide association genotyping array tailored for transplantation-specific studies. Genome Med. 2015;7(1):90. doi: 10.1186/s13073-015-0211-x
   PubMedGoogle Scholar
• Petrus-Reurer S, Kumar P, Padrell Sánchez S, et al. Preclinical safety studies of human embryonic stem cell-derived retinal pigment epithelial cells for the treatment of age-related macular degeneration. Stem Cells Transl Med. 2020;9(8):936–953. doi: 10.1002/sctm.19-0396
   PubMed Web of Science ®Google Scholar
• Merkle FT, Ghosh S, Genovese G, et al. Biological insights from the whole genome analysis of human embryonic stem cells [Internet]. bioRxiv; 2020 [cited 2023 Apr 23]. p. 2020.10.26.337352. Available from: https://www.biorxiv.org/content/10.1101/2020.10.26.337352v1.
   Google Scholar
• Merkle FT, Ghosh S, Genovese G, et al. Whole-genome analysis of human embryonic stem cells enables rational line selection based on genetic variation. Cell Stem Cell. 2022;29(3):472–486.e7. doi: 10.1016/j.stem.2022.01.011
   PubMed Web of Science ®Google Scholar
• Iida T, Iwanami A, Sanosaka T, et al. Whole-genome DNA methylation analyses revealed epigenetic instability in tumorigenic human ips cell-derived neural stem/progenitor cells. Stem Cells. 2017;35(5):1316–1327. doi: 10.1002/stem.2581
   PubMed Web of Science ®Google Scholar
• McIntire E, Leonhard K, Taapken S, et al. G-Banded karyotyping of human pluripotent stem cell cultures. Methods Mol Biol. 2021;2239:251–268.
   PubMedGoogle Scholar
• Ashton RS, Peltier J, Fasano CA, et al. High-throughput screening of gene function in stem cells using clonal microarrays. Stem Cells. 2007;25(11):2928–2935. doi: 10.1634/stemcells.2007-0468
   PubMed Web of Science ®Google Scholar
• Uffelmann E, Huang QQ, Munung NS, et al. Genome-wide association studies. Nat Rev Methods Primers. 2021;1(1):1–21. doi: 10.1038/s43586-021-00056-9
   Google Scholar
• Runheim H, Pettersson M, Hammarsjö A, et al. The cost-effectiveness of whole genome sequencing in neurodevelopmental disorders. Sci Rep. 2023;13(1):6904. doi: 10.1038/s41598-023-33787-8
   PubMed Web of Science ®Google Scholar
• Nas K, Yazmalar L, Şah V, et al. Rehabilitation of spinal cord injuries. World J Orthop. 2015;6(1):8–16. doi: 10.5312/wjo.v6.i1.8
   PubMed Web of Science ®Google Scholar
• Leemhuis E, Favieri F, Forte G, et al. Integrated neuroregenerative techniques for plasticity of the injured spinal cord. Biomedicines. 2022;10(10):2563. doi: 10.3390/biomedicines10102563
   PubMed Web of Science ®Google Scholar
• Griffin JM, Bradke F. Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem. EMBO Mol Med. 2020;12(3):e11505. doi: 10.15252/emmm.201911505
   PubMed Web of Science ®Google Scholar
• Moritz CT, Ambrosio F. Regenerative rehabilitation: combining stem cell therapies and activity dependent stimulation. Pediatr Phys Ther. 2017;29:S10–S15. doi: 10.1097/PEP.0000000000000378
   PubMed Web of Science ®Google Scholar
• Hillen BK, Abbas JJ, Jung R. Accelerating locomotor recovery after incomplete spinal injury. Ann N Y Acad Sci. 2013;1279(1):164–174. doi: 10.1111/nyas.12061
   PubMedGoogle Scholar
• Hwang DH, Park HH, Shin HY, et al. Insulin-like growth factor-1 receptor dictates beneficial effects of treadmill training by regulating survival and migration of neural stem cell grafts in the injured spinal cord. Exp Neurobiol. 2018;27(6):489–507. doi: 10.5607/en.2018.27.6.489
   PubMed Web of Science ®Google Scholar
• Burns AS, Marino RJ, Kalsi-Ryan S, et al. Type and timing of rehabilitation following acute and subacute spinal cord injury: a systematic review. Global Spine J. 2017;7(3_suppl):175S–194S. doi: 10.1177/2192568217703084
   PubMedGoogle Scholar
• Clark JMR, Krause JS. Life satisfaction in individuals with long-term traumatic spinal cord injury: an investigation of associated biopsychosocial factors. Arch Phys Med Rehabil. 2022;103(1):98–105. doi: 10.1016/j.apmr.2021.09.002
   PubMed Web of Science ®Google Scholar
• Baranovskii DS, Klabukov ID, Arguchinskaya NV, et al. Adverse events, side effects and complications in mesenchymal stromal cell-based therapies. Stem Cell Investig. 2022;9:7. doi: 10.21037/sci-2022-025
   PubMedGoogle Scholar
• Curt A, Hsieh J, Schubert M, et al. The damaged spinal cord is a suitable target for stem cell transplantation. Neurorehabil Neural Repair. 2020;34(8):758–768. doi: 10.1177/1545968320935815
   PubMed Web of Science ®Google Scholar
• Wu X, Liu J, Tanadini LG, et al. Challenges for defining minimal clinically important difference (MCID) after spinal cord injury. Spinal Cord. 2015;53(2):84–91. doi: 10.1038/sc.2014.232
   PubMed Web of Science ®Google Scholar
• de Groot S, Bevers G, Post MWM, et al. Effect and process evaluation of implementing standardized tests to monitor patients in spinal cord injury rehabilitation. Disabil Rehabil. 2010;32(7):588–597. doi: 10.3109/09638280903174414
   PubMed Web of Science ®Google Scholar
• Fehlings MG, Pedro K, Hejrati N. Management of acute spinal cord injury: where have we been? where are we now? Where are we going? J Neurotrauma. 2022;39(23–24):1591–1602. doi: 10.1089/neu.2022.0009
   PubMed Web of Science ®Google Scholar
• Freund P, Seif M, Weiskopf N, et al. MRI in traumatic spinal cord injury: from clinical assessment to neuroimaging biomarkers. Lancet Neurol. 2019;18(12):1123–1135. doi: 10.1016/S1474-4422(19)30138-3
   PubMed Web of Science ®Google Scholar
• Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–415. doi: 10.1016/0197-2456(89)90005-6
   PubMedGoogle Scholar
• Kwon BK, Bloom O, Wanner IB, et al. Neurochemical biomarkers in spinal cord injury. Spinal Cord. 2019;57(10):819–831. doi: 10.1038/s41393-019-0319-8
   PubMed Web of Science ®Google Scholar